These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30547858)

  • 1. Nonconventional Therapeutics against
    Grunenwald CM; Bennett MR; Skaar EP
    Microbiol Spectr; 2018 Nov; 6(6):. PubMed ID: 30547858
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.
    Chung PY; Toh YS
    Pathog Dis; 2014 Apr; 70(3):231-9. PubMed ID: 24453168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations and caveats in anti-virulence drug development.
    Maura D; Ballok AE; Rahme LG
    Curr Opin Microbiol; 2016 Oct; 33():41-46. PubMed ID: 27318551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and virulence of
    Cheung GYC; Bae JS; Otto M
    Virulence; 2021 Dec; 12(1):547-569. PubMed ID: 33522395
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive review.
    Gopikrishnan M; Haryini S; C GPD
    J Basic Microbiol; 2024 May; 64(5):e2300579. PubMed ID: 38308076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Strategies Targeting Virulence Factors of Staphylococcus aureus and Pseudomonas aeruginosa.
    François B; Luyt CE; Stover CK; Brubaker JO; Chastre J; Jafri HS
    Semin Respir Crit Care Med; 2017 Jun; 38(3):346-358. PubMed ID: 28578557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.
    Fleitas Martínez O; Cardoso MH; Ribeiro SM; Franco OL
    Front Cell Infect Microbiol; 2019; 9():74. PubMed ID: 31001485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage endolysins as new therapeutic options for multidrug resistant
    Belete MA; Tadesse S; Tilahun M; Alemayehu E; Saravanan M
    Front Cell Infect Microbiol; 2024; 14():1397935. PubMed ID: 38953006
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance.
    Bhardwaj AK; Vinothkumar K; Rajpara N
    Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):68-83. PubMed ID: 23394143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections.
    Magana M; Ioannidis A; Magiorkinis E; Ursu O; Bologa CG; Chatzipanagiotou S; Hamblin MR; Tegos GP
    Curr Pharm Des; 2015; 21(16):2058-72. PubMed ID: 25760340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.
    Kane TL; Carothers KE; Lee SW
    Curr Drug Targets; 2018; 19(2):111-127. PubMed ID: 27894236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release.
    Brackman G; Breyne K; De Rycke R; Vermote A; Van Nieuwerburgh F; Meyer E; Van Calenbergh S; Coenye T
    Sci Rep; 2016 Feb; 6():20321. PubMed ID: 26828772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Pathogenic Efficacy and Molecular Targets of a Polyherbal Wound- Care Formulation (Herboheal) Against Staphylococcus aureus.
    Patel P; Joshi C; Kothari V
    Infect Disord Drug Targets; 2019; 19(2):193-206. PubMed ID: 30345928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections.
    Khan BA; Yeh AJ; Cheung GY; Otto M
    Expert Opin Investig Drugs; 2015 May; 24(5):689-704. PubMed ID: 25704585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus.
    Assis LM; Nedeljković M; Dessen A
    Drug Resist Updat; 2017 Mar; 31():1-14. PubMed ID: 28867240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative approaches to treat
    Richter K; Van den Driessche F; Coenye T
    Essays Biochem; 2017 Feb; 61(1):61-70. PubMed ID: 28258230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VraR Binding to the Promoter Region of
    Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus.
    Dawgul M; Baranska-Rybak W; Kamysz E; Karafova A; Nowicki R; Kamysz W
    Future Med Chem; 2012 Aug; 4(12):1541-51. PubMed ID: 22917244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Assessment of Bacteriophage and Antibiotic Activity against Multidrug-Resistant
    Kaźmierczak N; Grygorcewicz B; Roszak M; Bochentyn B; Piechowicz L
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Resistance and the MRSA Problem.
    Vestergaard M; Frees D; Ingmer H
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30900543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.